With populations around the world getting older and chronic disease burden increasing, demand for healthcare services continues to increase.
I expect this trend to continue for several decades, which I feel makes the healthcare sector a great place to look for investments.
Three healthcare shares that I feel could be worth watching closely in 2020 are listed below. Here’s why I like them:
Alcidion Group Ltd (ASX: ALC)
Alcidion is a growing informatics solutions company. It provides software that aims to improve the efficacy and cost of delivering services to patients and reduce hospital-acquired complications. Due to the quality of its portfolio and the growing trend for healthcare organisations to shift to a paperless environment, I believe it is well-placed for strong growth over the coming years.
Nanosonics Ltd (ASX: NAN)
Nanosonics is the infection control specialist behind the industry-leading trophon EPR disinfection system for ultrasound probes. I think this product alone has the potential to underpin solid earnings growth over the coming years. This is thanks to its massive global market opportunity, recurring revenues, and favourable guideline changes. However, Nanosonics will not be a one-trick pony for much longer. It has a number of new products in its pipeline targeting unmet needs. The first is expected to launch early in FY 2021.
Paradigm Biopharmaceuticals Ltd (ASX: PAR)
Paradigm is a biopharmaceutical company which is repurposing Pentosan Polysulfate Sodium (PPS) to treat osteoarthritis. The trial results of the drug, ZILOSUL, have been very promising, which is a big positive given its market opportunity. Management notes that there are over 31 million osteoarthritis sufferers in the United States alone. Another positive is its cash balance of ~$75 million. I believe this is more than sufficient to see Paradigm through to a commercial launch of ZILOSUL if it gets to that stage.
The post 3 exciting ASX healthcare shares to watch in 2020 appeared first on Motley Fool Australia.
And here are more growth shares that I'm tipping to be strong performers in 2020.
Our Motley Fool experts have just released a brand new FREE report, detailing 5 dirt cheap shares that you can buy today.
One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…
Another is a diversified conglomerate trading near a 52-week low all while offering a 2.8% fully franked yield...
Plus 3 more cheap bets that could position you to profit over the next 12 months!
See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.
- Man bets $221,666 on one ASX stock
- Top analysts name their top 3 ASX blue chip shares for 2019
- 3 quality dividend shares to boost your income
- NEW: Free report names top 3 ASX dividend shares to buy for 2019
- 5 Stocks for Potentially Building Wealth After 50
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of Alcidion Group Ltd. The Motley Fool Australia owns shares of and has recommended Nanosonics Limited. The Motley Fool Australia has recommended Alcidion Group Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2019